嘧啶酮衍生物的微波合成

在微波辅助下,Baylis-Hillman加成物与4-氨基-6-氯嘧啶或2-氨基-噻唑反应,快速合成了两类嘧啶酮衍生物——3-取代-7-氯-4H-嘧啶[1,2-b]哒嗪-4-酮和6-取代-5H-噻唑[3,2-a]嘧啶-5-酮,收率81%～98%,其结构经1H NMR,13C NMR,IR和MS确证。     

1,3-二氢苯并[c]异噻唑2,2-二氧化物的合成工艺改进

1,3-二氢苯并[c]异噻唑2,2-二氧化物是常见的药物骨架，本文以邻氯氯苄和亚硫酸钠为原料，经亲核取代、酰氯化、酰胺化及偶联环化反应，以55%的总收率和99%的纯度合成了1,3-二氢苯并[c]异噻唑2,2-二氧化物，其结构经¹H NMR， ¹³C NMR和FT-IR确证。     

新型含咔唑环和芳环/芳稠杂环的N-酰腙衍生物的合成及蛋白酪氨酸磷酸酶1B(PTP1B)抑制活性评价

为寻找高效、低毒的新型蛋白酪氨酸磷酸酶1B(PTP1B)抑制剂,设计并合成出了一系列新型含咔唑环和芳环/芳稠杂环的N-酰腙衍生物6～8和11.利用IR、1H NMR、13C NMR和2D NMR(包括1H-1H COSY和NOESY)谱及元素分析确定了其结构和构型.评价了目标化合物对PTP1B的抑制活性.实验结果表明,目标化合物对PTP1B均有较强的抑制活性,除了化合物N'-[9-(2-氯噻唑-5-甲基)咔唑-3-亚甲基]-2-苯氨基乙酰肼(6a)、N'-[9-(2-氯噻唑-5-甲基)咔唑-3-亚甲基]-2-(4-甲基苯氨基)乙酰肼(6b)、N'-[9-(2-氯噻唑-5-甲基)咔唑-3-亚甲基]-2-(3-硝基苯氨基)乙酰肼(6g)和N'-[9-(2-氯噻唑-5-甲基)咔唑-3-亚甲基]-2-(4-硝基苯氨基)乙酰肼(6h)外,其它化合物的活性均高于阳性对照药物齐墩果酸,其中N,N'-[(9-丁基咔唑基)-3,6-二亚甲基]-2,2'-[二(4-硝基苯氨基)]双乙酰肼(11b)的活性最高,IC50=(0.89±0.06)μmol/L.利用分子对接分别研究了代表目标化合物N'-[9-(2-氯噻唑-5-甲基)咔唑-3-亚甲基]-2-(4-溴苯氨基)乙酰肼(6d)、N'-[9-(2-氯噻唑-5-甲基)咔唑-3-亚甲基]-2-((2-(1-萘氧基)甲基)苯并咪唑-1-基)乙酰肼(7f)和11b与PTP1B酶的结合模式.     

新型含醚结构噻唑类化合物的合成及其抑菌活性

根据活性基团拼接原理,以对羟基硫代苯甲酰胺和4,4,4-三氟-2-氯乙酰乙酸乙酯为原料,经环化反应制得中间体2-(4'-羟基)苯基-4-三氟甲基-5-噻唑甲酸乙酯(3);3与取代苄基氯或氯乙酸反应合成了5个新型的含醚结构噻唑类化合物(5a~5e),其结构经1H NMR,ESI-MS和元素分析表征。用离体平皿法考察了5a~5e对小麦赤霉病和纹枯病细菌的抑菌活性。结果表明,5a~5e均有一定的抑制活性。其中2-(4'-间氟苄氧基苯基)-4-三氟甲基噻唑-5-甲酸乙酯5c抑菌活性最好,对小麦赤霉病和纹枯病细菌的抑菌活性分别为37.8%和53.3%。     

新型N-(4,6-二取代嘧啶-2-基)-1-[取代吡啶(噻唑)甲基]-5-甲基-1H-1,2,3-三唑基-4-甲酰胺的合成与除草活性

为了寻找新型低毒性的潜在除草剂, 以2-氯-5-(氯甲基)吡啶和2-氯-5-(氯甲基)噻唑为起始原料, 经过叠氮化, 然后与乙酰乙酸乙酯的环化, 水解, 卤化, 最后与2-氨基-4,6-二取代嘧啶的缩合反应, 合成了9种未见文献报道的目标化合物, 其结构经IR, ¹H NMR, MS 和元素分析确证. 初步的生物活性测试结果表明, 所测目标化合物在100 mg/L浓度下显示出良好的除草活性.     

新型含2-取代-1,3-噻唑烷和噻唑环的亚胺类化合物的合成及生物活性

通过4-[(2-氰基亚胺基-1,3-噻唑烷-3-基)甲基]-2-氨基噻唑与取代苯甲醛的缩合反应, 合成了14个新型含2-取代- 1,3-噻唑烷和噻唑环的亚胺类化合物5. 所有化合物的结构均经1H NMR和元素分析确证, 并通过X射线单晶衍射分析测定了化合物5a的晶体结构. 初步生物活性试验结果表明, 部分目标化合物具有一定的杀菌活性和植物生长调节活性.     

N-(4-叔丁基-5-苄基噻唑-2-基)氨基乙酰胺的合成与抗肿瘤活性

采用衍生法,在N-[4-叔丁基-5-(4-氯苄基)噻唑-2-基]脂肪酰胺酰基的α-位,插入氨基,设计合成了N-(4-叔丁基-5-苄基噻唑-2-基)氨基乙酰胺衍生物.以4,4-二甲基-1-芳基-3-戊酮为原料,经4-叔丁基-5-苄基-2-氨基噻唑(3),再经氯乙酰化和取代反应得21个N-(4-叔丁基-5-苄基噻唑-2-基)氨基乙酰胺(1),其结构经~1H NMR、~(13)C NMR和元素分析确证.噻唑蓝(MTT)法体外抗肿瘤活性测试表明,该类新化合物对肺癌细胞(A549)、宫颈癌细胞(Hela)和乳腺癌细胞(MCF-7)具有抗肿瘤活性.其中N-[4-叔丁基-5-(胡椒基)噻唑-2-基]吗啉基乙酰胺(1t)对Hela细胞的抑制活性最好;对优选化合物1t进行了AO/EB双染和细胞周期实验,流式细胞仪分析表明,化合物1t可显著诱导肿瘤细胞凋亡,阻滞Hela细胞有丝分裂在S期.     

N-{1-[取代吡啶(噻唑)甲基]-5-甲基-1H-1,2,3-三唑-4-甲酰基}-N''-(芳氧乙酰)肼的合成与生物活性

采用2-氯-5-(氯甲基)吡啶和2-氯-5-(氯甲基)噻唑为原料,经过叠氮化、乙酰乙酸乙酯环化、水解、酰氯化,然后与芳氧乙酰肼的缩合反应,合成了9种目标化合物,其结构经1H NMR、IR、MS和元素分析测试技术确证,初步的生物活性测定结果表明,目标化合物在100 mg/L质量浓度下显示出良好的除草活性,但杀虫活性较弱.     

含4-噻唑啉酮环的新烟碱类化合物的合成及生物活性

根据生物等排原理和新烟碱类化合物与乙酰胆碱酯酶的作用机理, 以4-噻唑啉酮(4)为中间体设计合成了2-取代-3-(2-氯-5-吡啶亚甲基)-4-氰基亚胺基-1,3-噻唑烷(8a~8c)和5-芳基次甲基-2-芳基-3-(2-氯-5-吡啶亚甲基)-4-噻唑啉酮(5a~5e)两类化合物. 中间体(4)由醛、胺和巯基乙酸缩合得到. 所有化合物的结构均经元素分析和1H NMR确证. 初步生物活性试验结果表明, 部分化合物具有一定的杀菌活性和促进黄瓜子叶生根活性, 化合物8b显示出很好的抗HIV-1蛋白酶活性.     

2,5-取代-1,3,4-噁二唑衍生物的合成与杀菌活性

利用生物活性亚结构拼接原理,将吡啶环、噻唑环引入到1,3,4-噁二唑母体结构中,设计并合成了一系列新型含吡啶(噻唑)的1,3,4-噁二唑衍生物.通过IR,1H NMR,EI-MS及元素分析等方法对所合成的化合物进行了结构表征.代表化合物2-(6-氯吡啶-3-甲硫基)-5-(吡啶-4-基)-1,3,4-噁二唑(I)经单晶X衍射证实了结构.初步测定了所合成化合物的杀菌活性,并比较了在1,3,4-噁二唑母体结构中引入噻唑杂环和引入吡啶杂环后其杀菌活性的差异.结果表明:目标化合物对测试的5种菌均具有一定的杀菌活性,对水稻纹枯病的抑制效果普遍优于对其它菌种的抑制效果;在1,3,4-噁二唑母体结构中引入噻唑杂环比引入吡啶杂环对其杀菌活性更有利.     

Synthesis of some new 1‐acyl‐5‐aryl‐3‐(5‐methyl‐1‐p‐tolyl‐1H‐1,2,3‐triazol‐4‐yl)‐4,5‐dihydro‐1H‐pyrazole

Some new compounds (E)‐3‐aryl‐1‐(5‐methyl‐1‐p‐tolyl‐1H‐1,2,3‐triazol‐4‐yl)‐prop‐2‐en‐1‐ones 5a–e were prepared by 1‐(5‐methyl‐1‐p‐tolyl‐1H‐1,2,3‐triazol‐4‐yl)‐ethanone and various aromatic aldehydes. Then one pot reaction was happened by compounds 5a–e with hydrazine hydrate in acetic acid or propionic acid, respectively, to give the title compounds 1acyl‐5‐aryl‐3‐(5‐methyl‐1‐p‐tolyl‐1H‐1,2,3‐triazol‐4‐yl)‐4,5‐dihydro‐1H‐pyrazoles 6a–i . All structures were established by MS, IR, CHN, ¹H‐NMR and ¹³C‐NMR spectral data. J. Heterocyclic Chem., (2012).     

Stereoselective synthesis and biological activities of O‐(E)‐1‐{1‐[(6‐chloropyridin‐3‐yl)methyl]‐5‐methyl‐1H‐1,2,3‐triazol‐4‐yl}ethyleneamino‐O‐ethyl‐O‐arylphosphorothioates

To find novel lead compounds having high insecticidal activity, a series of phosphorothioate derivatives containing 1,2,3‐triazole and pyridine rings were synthesized by the reaction of 1‐{1‐[(6‐chloropyridin‐3‐yl)methyl]‐5‐methyl‐1H‐1,2,3‐triazol‐4‐yl}ethanone oxime with phosphorochloridothioates. Their structures were confirmed by IR, ¹H NMR, ³¹P NMR, mass spectrometry, and elemental analyses. The structure of 6c was determined by single crystal X‐ray diffraction, which is thermodynamically stable E isomer. The results of preliminary bioassay indicate that some title compounds possess insecticidal activity to some extent. © 2008 Wiley Periodicals, Inc. Heteroatom Chem 19:15–20, 2008; Published online in Wiley InterScience ( www.interscience.wiley.com ). DOI 10.1002/hc.20367     

Synthesis and Antibacterial Activities of 2‐(1‐Aryl‐5‐Methyl‐1,2,3‐triazol‐4‐yl)‐1,3,4‐Oxadiazole Derivatives

Eighteen novel 2‐(1‐aryl‐5‐methyl‐1,2,3‐triazol‐4‐yl)‐1,3,4‐oxadiazole derivatives and two acylhydrazone intermediate compounds were synthesized by various pathways starting from 1‐aryl‐5‐methyl‐1,2,3‐triazol‐4‐formhydrazide ( 1 ). All products were identified by spectroscopic analysis, and 2‐(1‐aryl‐5‐methyl‐1,2,3‐triazol‐4‐yl)‐5‐benzalthio‐1,3,4‐oxadiazole was further validated by X‐ray crystallography. Results from primary antibacterial activity tests indicated that most of the compounds were effective against E. coli, P. aeruginosa, B. subtilis and S. aureus.     

Synthesis of novel isoindolone‐based medium‐sized macromolecules and triazole containing heterocyclic compounds

A series of novel isoindolone‐based macromolecules of medium‐sized heterocyclic rings, such as 7,8‐dihydro‐6H‐benzo[4,5][1,6,3]dioxazonino[2,3‐a]isoindol‐14(9aH)‐one derivatives ( 5a‐l ), were synthesized and its frame work incorporating with a triazole moiety on phenol, ie, 2‐(4‐((1‐(2‐methoxyphenyl)‐1H‐1,2,3‐triazol‐4‐yl)methoxy)phenyl)isoindoline‐1,3‐dione ( 9a‐f ) and also a triazole moiety on carboxylic acid, ie, (1‐(2‐methoxyphenyl)‐1H‐1,2,3‐triazol‐4‐yl)methyl 4‐(1,3‐dioxoisoindolin‐2‐yl)benzoate derivatives ( 13a‐e ) with various substitutions on aryl ring system have synthesized. All the synthesized compounds were characterized and confirmed with IR, ¹H NMR_, ¹³C NMR, and ESI mass spectral analysis.     

Synthesis of Some 7H‐s‐Triazolo[3,4‐b]‐1,3,4‐thiadiazine Derivatives

The cyclization of 1‐amino‐2‐mercapto‐5‐[5‐methyl‐1‐(4‐methylphenyl)‐1,2,3‐triazol‐4‐yl]‐1,3,4‐triazole with various α‐haloketone in absolute ethanol yields 7H‐3‐[5‐methyl‐1‐(4‐methylphenyl)‐1,2,3‐triazol‐4‐yl]‐6‐substituted‐s‐triazolo[3,4‐b]‐1,3,4‐thiadiazines and their structures are established by elemental analysis, MS, IR and ¹H NMR spectral data.     

An efficient synthesis of 5‐aryl‐4,5‐dihydro‐3‐(5‐methyl‐1‐p‐tolyl‐1H‐1,2,3‐triazol‐4‐yl)‐1‐(4‐phenylthiazol‐2‐yl)pyrazoles

Some new target products 5‐aryl‐4,5‐dihydro‐3‐(5‐methyl‐1‐p‐tolyl‐1H‐1,2,3‐triazol‐4‐yl)‐1‐(4‐phenylthiazol‐2‐yl)pyrazoles 5a , 5b , 5c , 5d , 5e , 5f , 5g , 5h , 5i , 5j have been synthesized by reaction of 2‐bromo‐1‐phenylethanone and compounds 4a , 4b , 4c , 4d , 4e , 4f , 4g , 4h , 4i , 4j which were prepared from the combination of thiosemicarbazide and (E)‐3‐aryl‐1‐(5‐methyl‐1‐p‐tolyl‐1H‐1,2,3‐triazol‐4‐yl)‐prop‐2‐en‐1‐ones 3a , 3b , 3c , 3d , 3e , 3f , 3g , 3h , 3i , 3j . All the structures were established by MS, IR, CHN, and ¹H NMR spectra data. Synthesis of structure diversity is applied. J. Heterocyclic Chem., (2011).     

Synthesis and Fungicidal Activity of (1Z, 3Z)‐4,4‐Dimethyl‐1‐substitutedphenyl‐2‐(1H‐1,2,4‐triazol‐1‐yl)‐pent‐1‐en‐3‐one O‐[2,4‐dimethylthiazole(or 4‐methyl‐1,2,3‐thiadiazole)]‐5‐carbonyl Oximes

A series of novel (Z)‐1‐tert‐butyl (or phenyl)‐2‐(1H‐1,2,4‐triazol‐1‐yl)‐ethanone O‐[2,4‐dimethylthiazole (or 4‐methyl‐1,2,3‐thiadiazole) ?5‐carbonyl] oximes 5a – 5c and (1Z, 3Z)‐4,4‐dimethyl‐1‐substitutedphenyl‐2‐(1H‐1,2,4‐triazol‐1‐yl)‐pent‐1‐en‐3‐one O‐[2,4‐dimethylthiazole (or 4‐methyl‐1,2,3‐thiadiazole)‐5‐carbonyl] oximes 6a – 6e were synthesized by the condensations of (Z)‐1‐tert‐butyl (or phenyl)‐2‐(1H‐1,2,4‐triazol‐1‐yl)‐ethanone oximes 3 or (1Z, 3Z)‐4,4‐dimethyl‐1‐substitutedphenyl‐2‐(1H‐1,2,4‐triazol‐1‐yl)‐pent‐1‐en‐3‐one oximes 4 with 2,4‐dimethylthiazole‐5‐carbonyl chloride or 4‐methyl‐1,2,3‐thiadiazole‐5‐carbonyl chloride in the basic condition. Their structures were confirmed by IR, ¹H NMR, mass spectroscopy, and elemental analyses. The results of preliminary bioassays showed the title compounds 5 and 6 exhibited moderate to good fungicidal activities. For example, compound 6c possessed 86.4% inhibition against Fusarium oxysporum, and compound 6b exhibited 86.4 and 100% inhibition against Fusarium oxysporum and Cercospora arachidicola Hori at the concentration of 50 mg/L, respectively.     

Synthesis and Pharmacological Evaluation of a Novel Series of 2‐((2‐Aryl thiazol‐4‐yl)methyl)‐5‐(alkyl/alkylnitrile thio)‐1,3,4‐oxadiazole Derivatives as Possible Antifungal Agents

In the present investigation, a novel series of 2‐[(2‐arylthiazol‐4‐yl)methyl]‐5‐(alkyl/alkylnitrile thio)‐1,3,4‐oxadiazole derivatives were synthesized by cyclo‐condensation of 2‐(2‐substituted thiazol‐4‐yl)aceto hydrazide with carbon disulfide followed by S‐alkylation with alkyl halide in dry acetone. All the newly synthesized compounds were characterized by spectral (IR, ¹H NMR, ¹³C NMR, mass, and elemental analysis) methods. The title compounds were screened for in vitro antifungal activity and most of the synthesized compounds show moderate to good antifungal activity.     

Synthesis of (3,5‐Aryl/methyl‐1H‐Pyrazol‐1‐yl)‐(5‐Arylamino‐2H‐1,2,3‐Triazol‐4‐yl)Methanone

Some new (3,5‐aryl/methyl‐1H‐pyrazol‐1‐yl)‐(5‐arylamino‐2H‐1,2,3‐triazol‐4‐yl)methanones were synthesized and characterized by ¹HNMR, ¹³C NMR, MS, IR spectra data and elemental analyses or high resolution mass spectra (HRMS). During the procedure, Dimroth rearrangement was used in this synthesis.     

Green One‐Pot Solvent‐Free Synthesis of Pyrazolo[1,5‐a]pyrimidines,Azolo[3,4‐d]pyridiazines,and Thieno[2,3‐b]pyridines Containing Triazole Moiety

Synthesis of pyrazolo[1,5‐a]pyrimidines, [1,2,4]triazolo[1,5‐a]pyrimidine, 8,10‐dimethyl‐2‐(5‐methyl‐1‐phenyl‐4,5‐dihydro‐1H‐1,2,3‐triazol‐4‐yl)pyrido[2′,3′:3,4]‐pyrazolo[1,5‐a]pyrimidine, benzo[4,5]imidazo[1,2‐a]pyrimidine via heterocyclic amines, and sodium 3‐hydroxy‐1‐(5‐methyl‐1‐phenyl‐1H‐1,2,3‐triazole‐4‐yl)prop‐2‐en‐1‐one were carried out. Also, synthesis of isoxazoles, and pyrazoles from sodium 3‐hydroxy‐1‐(5‐methyl‐1‐phenyl‐1H‐1,2,3‐triazole‐4‐yl)prop‐2‐en‐1‐one and hydroxymoyl chlorides and hydrazonoyl halides, respectively, were made. Analogously, (1,2,3‐triazol‐4‐yl)thieno[2,3‐b]pyridine derivatives were obtained from sodium 3‐hydroxy‐1‐(5‐methyl‐1‐phenyl‐1H‐1,2,3‐ triazole‐4‐yl)prop‐2‐en‐1‐one and cyanothioacetamide followed by its reacting with active methylene compounds. In addition to full characterization of all synthesized compounds, they were tested to evaluate their antimicrobial activities, and some compounds showed competitive activities to those of tetracycline, the typical antibacterial drug, and clotrimazole, the typical antifungal drug.